Related Experiment Video

Updated: Jun 11, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease

Anna Alisi1, Giorgio Bedogni, Rita De Vito

  • 1Liver Unit, Pediatric Hospital Bambino Gesù, IRCCS, Rome, Italy.

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
|June 29, 2010
PubMed

Insights

Portal chronic inflammation is not associated with liver fibrosis in Italian children with non-alcoholic fatty liver disease (NAFLD). This suggests that some NAFLD factors may differ between populations.

Area of Science:

  • Pediatric Gastroenterology
  • Hepatology
  • Clinical Research

Background:

  • Previous research indicated a link between portal chronic inflammation and liver fibrosis in American children with non-alcoholic fatty liver disease (NAFLD).
  • The non-alcoholic steato-hepatitis Clinical Research Network (NASH CRN) established criteria for diagnosing NAFLD and its associated pathologies.

Purpose of the Study:

  • To investigate if the association between portal chronic inflammation and liver fibrosis, observed in American children, is also present in Italian children with NAFLD.
  • To evaluate clinico-pathological correlates of NAFLD in a pediatric cohort.

Main Methods:

  • Retrospective analysis of liver biopsies from 144 Italian children (aged 3-18 years) diagnosed with NAFLD.
  • Diagnosis of NAFLD and portal chronic inflammation followed NASH CRN criteria.
  • Clinical data including anthropometry, body composition, liver enzymes, metabolic parameters, and blood pressure were collected.

Main Results:

  • The study found no association between portal chronic inflammation and steatosis, lobular inflammation, ballooning, or fibrosis in Italian children with NAFLD.
  • While most children had mild or more than mild portal chronic inflammation, only insulin resistance was significantly greater in those with more than mild inflammation.
  • The previously reported association between portal chronic inflammation and liver fibrosis was not confirmed in this cohort.

Conclusions:

  • The study could not confirm a clinico-pathological association between portal chronic inflammation and disease severity in Italian pediatric NAFLD patients.
  • Findings suggest that certain clinico-pathological aspects of pediatric NAFLD might be population-specific.
  • Further research is needed to understand geographic variations in NAFLD pathogenesis.
Abstract

More Related Videos

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Concept Videos

Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...